Permit Capital Stake in Blucora (BCOR) Has Cut as Market Valuation Rose; As Novo Nordisk A/S (NVO) Shares Rose, Hansberger Growth Investors LP Has Raised Stake by $308,826

December 8, 2017 - By Darrin Black

Permit Capital Llc decreased its stake in Blucora Inc (BCOR) by 16.56% based on its latest 2017Q2 regulatory filing with the SEC. Permit Capital Llc sold 76,300 shares as the company’s stock rose 29.25% with the market. The hedge fund held 384,329 shares of the technology company at the end of 2017Q2, valued at $8.15M, down from 460,629 at the end of the previous reported quarter. Permit Capital Llc who had been investing in Blucora Inc for a number of months, seems to be less bullish one the $934.05M market cap company. It closed at $20.25 lastly. It is down 147.59% since December 8, 2016 and is uptrending. It has outperformed by 130.89% the S&P500.

Hansberger Growth Investors Lp increased its stake in Novo Nordisk A/S (NVO) by 22.49% based on its latest 2017Q2 regulatory filing with the SEC. Hansberger Growth Investors Lp bought 7,353 shares as the company’s stock rose 15.20% with the market. The institutional investor held 40,050 shares of the major pharmaceuticals company at the end of 2017Q2, valued at $1.72 million, up from 32,697 at the end of the previous reported quarter. Hansberger Growth Investors Lp who had been investing in Novo Nordisk A/S for a number of months, seems to be bullish on the $125.01 billion market cap company. The stock decreased 1.06% or $0.55 during the last trading session, reaching $51.52. About 1.22 million shares traded. Novo Nordisk A/S (NYSE:NVO) has declined 23.93% since December 8, 2016 and is downtrending. It has underperformed by 40.63% the S&P500.

Analysts await Blucora, Inc. (NASDAQ:BCOR) to report earnings on February, 15. They expect $-0.31 earnings per share, down 47.62% or $0.10 from last year’s $-0.21 per share. After $-0.19 actual earnings per share reported by Blucora, Inc. for the previous quarter, Wall Street now forecasts 63.16% negative EPS growth.

More news for Blucora, Inc. (NASDAQ:BCOR) were recently published by: Prnewswire.com, which released: “Internet Stocks’ Research Reports Released on Remark, Weibo, Blucora, and Zillow” on December 05, 2017. Globenewswire.com‘s article titled: “Blucora Announces Amendment and Re-Pricing of Credit Facility” and published on November 29, 2017 is yet another important article.

Among 4 analysts covering Blucora (NASDAQ:BCOR), 4 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Blucora has $2300 highest and $10 lowest target. $16.33’s average target is -19.36% below currents $20.25 stock price. Blucora had 9 analyst reports since August 22, 2015 according to SRatingsIntel. Benchmark maintained the shares of BCOR in report on Monday, August 24 with “Buy” rating. The rating was maintained by Wedbush with “Outperform” on Friday, February 12. The firm has “Buy” rating given on Saturday, August 22 by Benchmark. The firm earned “Outperform” rating on Monday, May 2 by Barrington Research. The stock of Blucora, Inc. (NASDAQ:BCOR) has “Buy” rating given on Friday, April 29 by Craig Hallum. The stock has “Buy” rating by Benchmark on Wednesday, July 26. The rating was maintained by Benchmark on Tuesday, February 16 with “Buy”. The stock of Blucora, Inc. (NASDAQ:BCOR) has “Outperform” rating given on Friday, October 28 by Barrington Research.

More notable recent Novo Nordisk A/S (NYSE:NVO) news were published by: Fool.com which released: “Here’s Why Novo Nordisk A/S Gained 12% in August” on September 06, 2017, also Benzinga.com with their article: “Benzinga’s Top Upgrades, Downgrades For December 6, 2017” published on December 06, 2017, Fool.com published: “Novo Nordisk A/S Continues Its Comeback” on August 14, 2017. More interesting news about Novo Nordisk A/S (NYSE:NVO) were released by: Fool.com and their article: “Why Novo Nordisk A/S (ADR) Jumped 10.6% In May” published on June 10, 2017 as well as Seekingalpha.com‘s news article titled: “Portfolio Update – Novo Nordisk Purchased” with publication date: November 22, 2016.

Hansberger Growth Investors Lp, which manages about $2.32B and $73.37M US Long portfolio, decreased its stake in Canadian Pacific Railway Limit (NYSE:CP) by 12,526 shares to 45,933 shares, valued at $7.39 million in 2017Q2, according to the filing. It also reduced its holding in Asml Holding Nv (NASDAQ:ASML) by 19,260 shares in the quarter, leaving it with 70,524 shares, and cut its stake in Hdfc Bank Ltd (NYSE:HDB).

Among 13 analysts covering Novo Nordisk (ADR) (NYSE:NVO), 6 have Buy rating, 0 Sell and 7 Hold. Therefore 46% are positive. Novo Nordisk (ADR) had 17 analyst reports since August 28, 2015 according to SRatingsIntel. The firm has “Neutral” rating given on Wednesday, September 6 by Bank of America. The firm has “Underperform” rating by Bank of America given on Friday, October 28. The firm has “Overweight” rating given on Friday, December 1 by Morgan Stanley. HSBC upgraded the stock to “Hold” rating in Wednesday, August 31 report. Goldman Sachs upgraded the shares of NVO in report on Monday, February 15 to “Conviction Buy” rating. The firm has “Hold” rating by DNB Markets given on Monday, October 31. The stock of Novo Nordisk A/S (NYSE:NVO) has “Equal-Weight” rating given on Thursday, September 1 by Morgan Stanley. The firm earned “Strong Buy” rating on Monday, October 19 by Jyske Bank. The stock of Novo Nordisk A/S (NYSE:NVO) has “Buy” rating given on Wednesday, December 6 by Bank of America. Leerink Swann initiated the stock with “Market Perform” rating in Friday, August 28 report.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.




Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: